A detailed history of Peoples Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Peoples Bank holds 3,774 shares of ABBV stock, worth $671,809. This represents 0.38% of its overall portfolio holdings.

Number of Shares
3,774
Previous 4,058 7.0%
Holding current value
$671,809
Previous $696,000 7.04%
% of portfolio
0.38%
Previous 0.36%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$163.84 - $199.33 $46,530 - $56,609
-284 Reduced 7.0%
3,774 $745,000
Q2 2024

Jul 22, 2024

BUY
$154.79 - $180.76 $69,500 - $81,161
449 Added 12.44%
4,058 $696,000
Q1 2024

May 03, 2024

BUY
$159.82 - $182.1 $27,009 - $30,774
169 Added 4.91%
3,609 $657,000
Q4 2023

Jan 25, 2024

SELL
$137.6 - $154.97 $25,593 - $28,824
-186 Reduced 5.13%
3,440 $533,000
Q3 2023

Oct 26, 2023

BUY
$133.59 - $154.65 $7,881 - $9,124
59 Added 1.65%
3,626 $540,000
Q2 2023

Jul 28, 2023

BUY
$132.51 - $164.9 $55,256 - $68,763
417 Added 13.24%
3,567 $480,000
Q1 2023

Apr 24, 2023

SELL
$144.61 - $166.54 $35,140 - $40,469
-243 Reduced 7.16%
3,150 $502,000
Q4 2022

Jan 31, 2023

BUY
$138.31 - $165.87 $130,841 - $156,913
946 Added 38.66%
3,393 $548,000
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $18,923 - $21,704
-141 Reduced 5.45%
2,447 $328,000
Q2 2022

Jul 29, 2022

SELL
$137.62 - $174.96 $2,064 - $2,624
-15 Reduced 0.58%
2,588 $396,000
Q1 2022

May 03, 2022

BUY
$131.98 - $163.75 $55,695 - $69,102
422 Added 19.35%
2,603 $422,000
Q4 2021

Jan 27, 2022

SELL
$107.43 - $135.93 $5,908 - $7,476
-55 Reduced 2.46%
2,181 $295,000
Q3 2021

Oct 27, 2021

SELL
$106.4 - $120.78 $1,064 - $1,207
-10 Reduced 0.45%
2,236 $242,000
Q2 2021

Aug 02, 2021

BUY
$105.21 - $117.21 $236,301 - $263,253
2,246 New
2,246 $253,000
Q2 2019

Aug 07, 2019

SELL
$65.7 - $83.98 $240,133 - $306,946
-3,655 Closed
0 $0
Q1 2019

May 06, 2019

SELL
$77.14 - $90.79 $30,856 - $36,316
-400 Reduced 9.86%
3,655 $295,000
Q4 2018

Feb 26, 2019

BUY
$77.85 - $96.01 $64,615 - $79,688
830 Added 25.74%
4,055 $374,000
Q3 2018

Oct 31, 2018

SELL
$88.91 - $98.84 $6,223 - $6,918
-70 Reduced 2.12%
3,225 $305,000
Q2 2018

Jul 27, 2018

SELL
$89.78 - $106.23 $57,279 - $67,774
-638 Reduced 16.22%
3,295 $305,000
Q1 2018

Apr 25, 2018

BUY
$92.01 - $123.21 $29,903 - $40,043
325 Added 9.01%
3,933 $372,000
Q4 2017

Feb 02, 2018

BUY
$89.56 - $98.21 $34,301 - $37,614
383 Added 11.88%
3,608 $349,000
Q3 2017

Oct 23, 2017

BUY
$69.85 - $89.22 $225,266 - $287,734
3,225
3,225 $287,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Peoples Bank Portfolio

Follow Peoples Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peoples Bank , based on Form 13F filings with the SEC.

News

Stay updated on Peoples Bank with notifications on news.